Issue 5/2025
Content (11 Articles)
The Tailored Biosimilar Approach: Expectations and Requirements
- Open Access
- Current Opinion
Elena Guillen, Sean Barry, Nils Jost, Niklas Ekman, Verena Knippel, Johanna Kuhlmann-Gottke, Julia Maier, Martina Weise, Andrea Laslop, René Anour, Ger van Zandbergen, Nadine Kirsch‑Stefan
Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges
- Escitalopram
- Leading Article
Sharmin Ghaznavi, Sarah G. Richter
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
- Hypercholesterolemia
- Review Article
Hui-Hui Liu, Sha Li, Jian-Jun Li
Current Drug Treatment for Acute and Recurrent Pericarditis
- Open Access
- Pericardial Disease
- Review Article
Aldo Bonaventura, Davide Santagata, Alessandra Vecchié, Antonio Abbate
The Potential of RNA Therapeutics in Treating Cardiovascular Disease
- Review Article
Gayatri Mainkar, Matteo Ghiringhelli, Lior Zangi
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
- Botulinum Toxin
- Systematic Review
Qiang Wang, Canyong Li, Yongfu Long, Bin Cao, Yangbo Lu, Gang Luo, Yaqiang Huang, Guiyan Huang, Hongxing Huang
Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology
- Open Access
- Correction
Bram C. Agema, Birgit C. P. Koch, Ron H. J. Mathijssen, Stijn L. W. Koolen